Showing 3581-3590 of 5956 results for "".
- IrisVision and Samsung Announce Partnership to Roll Out Vision Correction Software Platformhttps://modernod.com/news/irisvision-and-samsung-announce-partnership-to-roll-out-vision-correction-software-platform/2477229/Samsung Electronics and IrisVision announced a strategic partnership to roll out IrisVision’s technology worldwide. IrisVision’s vision correction software platform utilizes the power of Samsung’s industry leading Galaxy smartphones and XR devices and mobile AI platform to enable people
- AAO: Survey Reveals Most Americans Know a Lot Less About Eye Health Than They Think They Dohttps://modernod.com/news/aao-survey-reveals-most-americans-know-a-lot-less-about-eye-health-than-they-think-they-do/2477222/A survey conducted by The Harris Poll has uncovered key gaps in American’s knowledge of eye health, and what they don’t know is putting them at risk of vision loss, according to an AAO news release. With the number of people affected by potentially blinding eye diseases expected to do
- Gemini Therapeutics Enrolls First Patient in Phase 1 Study of GEM103 for Dry AMDhttps://modernod.com/news/gemini-therapeutics-enrolls-first-patient-in-phase-1-study-of-gem103-for-dry-amd/2477214/Gemini Therapeutics announced it has initiated enrollment in its phase 1 study of GEM103, a recombinant, native Complement Factor H (CFH) for the treatment of dry age-related macular degeneration. AMD is the leading cause of irreversible blindness in the western world—affecting millions of
- Eyevensys Closes $30M Series B Financinghttps://modernod.com/news/eyevensys-closes-30m-series-b-financing/2477210/Eyevensys announced that it has completed a $30 million Series B financing. The company will use the funds to continue the development of its clinical lead candidate EYS606 for the treatment of chronic noninfectious uveitis (NIU), including the launch of its Electro Study. This phase 2 trial, to
- With EyeCare Partners Deal, Swiss Firm Sees a Base for ‘Organic Growth, Expansion and Consolidation’ of U.S. Vision Markethttps://modernod.com/news/with-eyecare-partners-deal-swiss-firm-sees-a-base-for-organic-growth-expansion-and-consolidation-of-u-s-vision-market/2477176/In the second major acquisition of an eyecare practice management group this year, the Switzerland-based Partners Group announced Monday morning that it has agreed to make a significant investment in EyeCare Partners LLC (ECP). FFL Partners announced separately that it was selling the stake it ha
- Staar Surgical Announces FDA IDE Clinical Study Approvalhttps://modernod.com/news/staar-surgical-announces-fda-ide-clinical-study-approval-2/2477164/Staar Surgical announced that the FDA, in a letter dated December 6, 2019, stated that it has determined that Staar has provided sufficient data to support initiation of a human clinical study in the United States of the EVO/EVO+ VISIAN Implantable Collamer Lens for Myopia, and EVO/EVO+ VISIAN To
- Sight Sciences Appoints Erica Rogers to its Board of Directorshttps://modernod.com/news/sight-sciences-appoints-erica-rogers-to-its-board-of-directors/2477149/Sight Sciences announced the appointment of Erica Rogers to the company’s board of directors. Ms. Rogers, President and CEO of Silk Road Medical, is an experienced leader and entrepreneur in the medical device industry. She most recently led Silk Road Medical through FDA approval of
- CooperVision Earns Global Impact Award for Rebate Donation Program Resulting in $800,000 Raised for Optometry Giving Sighthttps://modernod.com/news/coopervision-earns-global-impact-award-for-rebate-donation-program-resulting-in-800000-raised-for-optometry-giving-sight/2477119/CooperVision offers a contact lens rebate donation program that enables consumers to designate all or part of their rebates to be given to Optometry Giving Sight (OGS). Seven years after the launch of that program, CooperVision has been recognized by 360insights, the company’s rebate and incentiv
- EnChroma Makes New Indoor Color Blind Glasses Available to the Publichttps://modernod.com/news/enchroma-makes-new-indoor-color-blind-glasses-available-to-the-public/2477109/EnChroma announced the launch of EnChroma Cx1 Indoor DT, an improved indoor lens designed specifically for Deutan-type color blindness. The glasses are now available for purchase online at
- Baring Private Equity Asia Agrees to Acquire Lumenishttps://modernod.com/news/baring-private-equity-asia-agrees-to-acquire-lumenis/2477103/Baring Private Equity Asia announced that its affiliated private equity funds have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT and gynecology from XIO. The transaction values Lumenis at an ent